TG Therapeutics, Inc.TGTXNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+21.1%
5Y CAGR+7.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+21.1%/yr
vs +6.1%/yr prior
5Y CAGR
+7.4%/yr
Recent acceleration
Acceleration
+15.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $392.00M | +57.7% |
| 2024 | $248.59M | +25.0% |
| 2023 | $198.90M | -9.9% |
| 2022 | $220.84M | -37.0% |
| 2021 | $350.67M | +28.1% |
| 2020 | $273.75M | +61.8% |
| 2019 | $169.21M | -3.1% |
| 2018 | $174.55M | +46.9% |
| 2017 | $118.86M | +50.2% |
| 2016 | $79.12M | - |